Innovator in precision oncology

At Tessellate Bio, we are creating a pipeline of first-in-class precision medicines that aim to address significant unmet needs for patients. Our lead programs are exploring new synthetic lethal interactions beyond Homologous Recombination Deficiency, uncovering novel biology and mechanisms. Committed to precision oncology approaches, we incorporate biomarker discovery and companion diagnostics early in our discovery programs.